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Objectives: To analyze the risk factors associated with the out-come of hospital 
acquired pneumonia (HAP). MethOds: A prospective observational study, carried 
out in a tertiary care teaching hospital. HAP patients who fulfill the inclusion criteria 
were identified and enrolled into the study after taking informed consent. Patients 
were followed from the day of diagnosis of HAP to till the day of discharge/death. 
The patient data like demography, social habits, co-morbid diseases, interventions 
(mechanical ventilation), severity assessment (APACHE II score) and clinical out-
come (discharge or death) were recorded in the case record forms. Univariate and 
Multivariate analysis were used to determine the association of the studied risk 
factors with clinical out-come. Results: Total of 505 patients were enrolled in the 
study. Among 505 HAP patients, 417 were improved and discharged; remaining 88 
patients were expired. The mean age of study patient population was 55.1±16.2 years 
and 38.4% patients were more than 60 years of age. The majority of patients were 
males n= 338 (66.9%). 230 (45.5%) patients were ventilated during their stay in the 
hospital. Twelve variables (age> 60 years, sex, mechanical ventilation, APACHE-II> 20, 
cardiac, pulmonary, renal, immunosuppression, diabetes mellitus, liver insuffi-
ciency, smoking and alcohol intake) were analyzed for possible association with the 
clinical outcome of HAP in Univariate analysis. Variables with statistical significance 
during the Univariate analysis were entered into the multivariate analysis. The 
following five variables were found statistically significant independent predic-
tors of out-come (mortality) in these patient population in multivariate analysis 
using logistic regression: mechanical ventilation (OR: 9.81; CI:4.98-19.35; p< 0.001), 
immunosuppression (OR:4.31; CI:1.65-11.27 ; p< 0.003), liver insufficiency (OR:3.69; 
CI:1.43-9.55; p< 0.007), APACHE II> 20 (OR:2.72; CI:1.56-4.76 ; p< 0.001) and male sex 
(OR:2.27; CI: 1.71-4.38; p< 0.015). cOnclusiOns: HAP has contributed significantly 
to mortality (17.4%). Mechanical ventilation, immunosuppression, Liver insuffi-
ciency, APACHE II score > 20 and male sex were found to be independent predictors 
of mortality in HAP patients.
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Objectives: Chronic Obstructive Pulmonary Disease (COPD) has become increas-
ingly a major public health problem. This study aimed to evaluate the risk factors 
for COPD based on data from several cities in eastern region of China. MethOds: 
Data were extracted from China Health Statistics for five most representative cities 
and provinces (Liaoning, Beijing, Tianjing, Shanghai and Guangdong) in the east-
ern region of China where rates of COPD were available. Descriptive statistics and 
multiple regression models were used to examine risk factors for COPD including 
gender, average family expenditure on cigarette, industrial dust, industrial emis-
sion of sulfur dioxide, average family income and average family expenditure on 
vegetables. Results: The total sample size was 150. Descriptive statistics indi-
cated strong correlations between the dependent variable rate of COPD and inde-
pendent variables – average family expenditure on cigarette, industrial emission 
of sulfur dioxide, industrial dust and average family expenditure on vegetables. 
Furthermore, multiple regression models showed that average family expenditure 
on cigarette, industrial emission of sulfur dioxide, industrial dust and average family 
expenditure on vegetables were the significant parameters that affected the rate of 
COPD. cOnclusiOns: Our analyses showed that, in the eastern region of China, 
cigarette smoking, sulfur dioxide emission, industrial dust and family expendi-
ture on vegetables were independent risk factors associated with the occurrence 
of COPD. To lessen the occurrence of COPD, people should quit smoking and modify 
dietary habit, while government authorities should enforce controlling for sulfur 
dioxide and industrial dust emissions.
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Objectives: Nowadays, health care costs of asthma are under pressure in all coun-
tries due to high prevalence, incidence and the chronic nature of disease. Hence, the 
aim of the study is to evaluate the lifetime cost of asthma for every new case and the 
incidence-based economic burden of asthma in Vietnam. MethOds: A Markov model 
with 5 states, including mild, intermittent, moderate and severe, has been built. The 
model has a cycle length of 1 year with the time horizon of life time. The population 
of 1000 new cases has been included in the model. The transition rates between states 
have been retrieved from relevant epidemiological studies, clinical trials and experts’ 
opinions. The treatment costs of asthma have been totaled for the life-time horizon 
using discount rate of 3%. The study has been conducted based on the perspective of 
insurance companies, therefore only direct medical costs have been evaluated. The 
prices of drugs and medical services have been averaged from the price-lists in 2013 
of some major hospitals in Vietnam. Results: The incidence-based cost of every new 
case of asthma in Vietnam accounts for 70,019,897 VND, in which costs for drugs and 
medical services account for 60.55% and 39.45%, respectively. The cost for diagnos-
ing and management of asthma within life-time per capita is 51,459,674 VND, which 
is around 2.77 times higher than for the costs of asthma exacerbations treatment 
(18,560,224 VND). With nearly 231,260 new cases of asthma annually, Vietnam has 
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Objectives: Respiratory diseases represent significant impact on health 
care resources. A cross-sectional, observational study, Asia-Pacific Burden of 
Respiratory Diseases (APBORD), was conducted to examine burden of disease 
in adults with respiratory diseases across 6 countries - India, Korea, Malaysia, 
Singapore, Taiwan, and Thailand. We examined the extent to which cough is a 
presenting symptom and reason for medical visits for participants with Asthma, 
Allergic Rhinitis (AR), COPD or Rhinosinusitis. MethOds: Participants aged ≥ 18 
years, presenting to a physician with primary diagnosis of Asthma, AR, COPD or 
Rhinosinusitis were enrolled. Participants completed a survey which contained 
questions related to demographics, respiratory symptoms, health care resource 
use and quality of life. Results: A total of 13,902 participants were screened, of 
which 7,030 were eligible and 5,250 enrolled. The highest percentage of partici-
pants receiving care for a respiratory disorder had primary diagnosis of AR 14.0%, 
(95%CI: 13.4%, 14.6%), followed by Asthma 13.5% (12.9%, 14.1%), Rhinosinusitis 
5.4% (4.6%, 5.3%) and COPD 4.9%, (5.0%, 5.7%). Cough or coughing up phlegm was 
reported as symptom by more than half the participants. Cough or coughing up 
phlegm was reported as the main reason for medical visit by more than 20% of 
participants. Among all symptoms reported, cough was most frequently reported 
by participants with a primary diagnosis of COPD (73%), followed by Asthma (61%), 
Rhinosinusitis (59%), and AR (47%). In addition, cough was the most frequently 
reported main reason for seeking medical care among participants with a pri-
mary diagnosis of COPD (43%), for Asthma (33%), for Rhinosinusitis (13%), and for 
AR (11%). cOnclusiOns: Cough is a prominent symptom and major driver of 
medical care for patients with Asthma, Allergic Rhinitis, COPD or Rhinosinusitis. 
These data suggest that patients presenting with cough should be investigated 
comprehensively for any underlying more serious respiratory disorders to help 
with appropriate disease management.
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Objectives: The aerborne allergenic content of the atmosphere varies accord-
ing to climate, geographyand vegetation. Furthermore, in the last few years, 
experimental data on pollen and subpollen-particles structure, the pathogenetic 
role of pollen and the interaction between pollen and air pollutants, gave new 
insights into the mechanisms of respiratory allergic diseases.We aim to evaluate 
Pollen morphology and total protein of Taraxacum officinale and Aster alpinus. To 
determine the Pollen morphology and total protein of Taraxacum officinale and 
Aster alpinus. MethOds: The Research is been done under the Biochemistry and 
Laboratory Department of Biomedicine School, HSUM with the help of Laboratory 
of School of Health Technology. Pollen morphology of Taraxacum officinale and 
Aster alpinus was investigated by light and microscopy. And total proteins was 
detected by Lowry method. Results: In Taraxacum pollen grain size (polar- egua-
toral diameter) ranged from 29.5±0.77 (24.7-34.6) µm to 25.1±0.76 (21.4-30.4) µm. 
And total proteins content 0.4mg/ml. Pollen grain of Aster alpinus size ranged from 
34.4±2.4 (22.7-38.5) µm to 22.7±0.88 (19.6-26.09) µm. Total proteins was contents 
0.9mg/ml. Both pollen walls are echinated, exine coated circular and yellow oil 
droplets. cOnclusiOns: Findings from the pollen grains comparison of mor-
phologic parameters demonstrated that the Aster alpinus pollen was larger than 
Taraxacum pollen.
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Objectives: To investigate the impact of seasonal variation on daily number 
of COPD hospital admissions using 6 years of hospital discharge data from the 
Iowa Hospital Association. MethOds: Inpatient admissions from 2006 to 2011 for 
persons 30 years of age or older were included if there was a principal ICD-9-CM 
diagnosis of COPD (491.xx; 492.xx; 496.xx).Generalized linear models extending 
Poisson regression and Negative Binomial model (to account for overdispersion) 
were fitted. Admission date was converted into an angle calledθ and treated as 
a continuous variable with a circular distribution. Sinθ and cosθ together were 
proposed to be used as the covariates representing seasonal effect. Subgroup 
analyses of age and sex were applied. Results: 34,563 inpatient admissions for 
COPD were identified. Admissions for COPD showed a strong seasonal pattern 
(P< 0.0001). The number of hospital admissions reached its maximum on Feb.21 
and its minimum on Aug. 23. The distribution is symmetric around the year. There 
were no differences of maximum and minimum dates between male, female and 
the overall population. However, for patients older than 65 years of age, the num-
ber of hospital admissions reached its maximum on Feb.25 and its minimum on 
Aug. 27. For patients 30-65 years of age, its maximum was on Feb.11; its mini-
mum was on Aug.12. The peaks were two weeks earlier than patients older than 
65 years of age. cOnclusiOns: The present findings support the conclusion that 
COPD hospitalization is higher in the winter. However, the busy period tends to 
be in late winter from Jan.7 until Apr.7, suggesting that it may be arbitrary to 
simply define winter as December to February when studying seasonal effect of 
COPD in the Midwest. The analytic method and the outcome of this study may 
help to allocate health care resources efficiently based on seasonal hospitaliza-
tion trend.
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regression model was used to determine difference of the number of hospitalization 
among groups of severity and health insurance. Costs were converted to $US using 
30.59 Thai-baht per $1US. Results: Among 1,982 patients included, the average age 
was 40.3±24.0 years with 60.7% male. A total of 1,936 patients were non-high risk 
patients, while 46 patients were high-risk patients. There were 1,293 patients under 
universal coverage schemes (UCS), 264 patients under social security schemes, and 
626 patients under civil servant medical benefit schemes (CSMBS). The average 
annual cost/patient was $598±871. In adjusted analyses, the health care cost of high-
risk patients was $67 higher than that of non-high risk patients (95% confidence 
interval (CI); $64–$69). The cost of patients under CSMBS was $109 (95%CI; $105-$113) 
higher than that of patients under UCS. cOnclusiOns: The health care costs in 
a cohort of patients with asthma were substantial and were higher in high-risk 
patients and patients under CSMBS.
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Objectives: This study aims to propose an appropriate statistical method to ana-
lyse the longitudinal health-related quality of life (HRQoL) data. MethOds: This 
was a longitudinal HRQoL study conducted among new smear positive pulmonary 
tuberculosis (PTB) patients diagnosed at the chest clinic of Penang General Hospital 
between March 2010 and February 2011. Eligible patients (i.e., literate and 18 years 
and above) were asked to self-complete the SF-36v2 questionnaire (either in Malay, 
Mandarin, Tamil or English) at the start of the treatment, after the intensive phase 
and at the end of the treatment. The mean physical component summary (PCS) and 
mental component summary (MCS) scores, ranging from 47–53, were considered 
equivalent to the general population norms. Repeated measures ANOVA (with single 
imputations) and linear mixed model were used to analyse the data. Results: A 
total of 216 patients completed the questionnaire at the start of their treatment. 
Out of these, 177 and 153 completed the questionnaire at the second and third 
follow-ups, respectively. Throughout the treatment, the mean PCS and MCS scores 
for the patients were less than 47. In repeated measures ANOVA analysis, level of 
education, diabetes, being alcoholic and cough with sputum were the significant 
predictors of PCS, whereas none of the covariates explained a significant variance 
in the MCS scores. In linear mixed model, ethnicity, marital status, being a smoker, 
productive cough and ≥ 3 TB-related symptoms were the significant predictors of 
PCS. Similarly, covariates such as ethnicity, hypertension, being a smoker, monthly 
income ≥ 1000 MYR and ≥ 3 TB-related symptoms significantly explained variance 
in the MCS scores. cOnclusiOns: The study’s findings indicated compromised 
health among the study participants even at the end of treatment. According to dif-
ferent findings obtained from both methods and the limited assumption in applying 
repeated measures ANOVA, linear mixed model was preferred to analyse this data.
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Objectives: Stevens - Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) 
are two forms of life-threatening dermatologic condition. The syndromes are very 
severe. They require lots of health care resource. However, there is little informa-
tion about health care resource utilization and cost of managing SJS/TEN. Thus, 
this study aimed to quantify health care use and cost of managing this syndrome 
in Thailand. MethOds: A retrospective study using an electronic health database 
from a 1000 bed- university-affiliated hospital in Thailand was undertaken. Patients 
who were admitted with SJS/TEN from 2002 to 2007 were included. The cost was 
determined using the ratio of cost-to-charge of the hospital for each year. The cost 
was converted to 2013 value by consumer price index. The cost was converted to US$ 
using 32.97 Thai-baht per 1 US$. Results: A total of 157 patients were included with 
56.1% of male. Average age of the patients was 45.3±23.0 years. Of those patients, 118 
patients were primarily diagnosed as SJS/TEN, while 39 patients were secondarily 
diagnosed as SJS/TEN. About 146 patients (93.0%) were diagnosed as SJS and the rest 
of them were diagnosed as TEN. The average length of stay (LOS) was 10.1±13.2 days 
for all patients. The LOS for primarily diagnosed patients was 6.8±4.8 days, while 
the LOS for secondarily diagnosed patients was 20.2±22.5 days. Most of patients 
(93.0%) were treated with systemic corticosteroids. Prednisolone was commonly 
used as an oral medication, while dexamethasone was usually used as an inject 
medication. The average cost of managing SJS/TEN for all patients was $1,012±2,563. 
The median cost was $342 (min-max; $11-$26,345). The average cost for primarily 
diagnosed patients was $519±724, while that for secondarily diagnosed patients was 
$2,536±4,713. cOnclusiOns: Health care utilization and cost of managing SJS/TEN 
in Thailand were substantial. Policy makers may consider allocating resources to 
support the development of strategies to minimize preventable SJS/TEN.
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the incidence-based economic burden of asthma within lifetime horizon of around 
16,193 billion VND. cOnclusiOns: Understanding the economic impact of asthma 
on society is fundamental to plan and implement relevant medical policies. The high 
incidence-based economic burden of asthma of around 16,193 billion VND should be 
considered to conduct the health care policies in Vietnam.
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Objectives: Atopic dermatitis (AD) is a chronic skin disease typically presenting in 
infancy. A literature review was conducted to identify pediatric AD cost estimates in 
Asia-Pacific (AP) countries. MethOds: An electronic literature search was conducted 
in PubMed, Google scholar, and Asian electronic reference databases to identify stud-
ies reporting on pediatric AD cost estimates in AP countries. Open text search terms 
were used to maximize the sensitivity of the search strategy. These searches were 
supplemented by manual reviews of bibliographies of the articles reporting cost esti-
mates and discussions with AD experts. Costs were inflated and converted to 2013 
US dollars. Results: Annual AD costs per patient were identified in Australia (cross-
sectional survey of 48 parents of AD children; age 4 months-15 years; total costs for 
all, mild, moderate, and severe cases: $2,745; $925; $3,301; $4,907, respectively; direct 
costs only: $1,400; $636; $1,577; $2,420, respectively), South Korea (cross-sectional 
survey of 196 parents of AD patients; age < 12 years; visiting an allergy clinic; total: 
$3,522; direct: $1,253); Indonesia (model-based; age 0-6; urban; total: $743; direct: 
$740), Malaysia (model-based; age 0-6; urban; total: $576; direct: $398), Philippines 
(model-based; age 0-6; urban; total: $371; direct: $363), Singapore (model-based; age 
0-6; urban; total: $1,097; direct: $957), and Thailand (model and chart review of 3,502 
AD children; age 0-5; direct costs; all, mild, moderate, and severe AD: $199, $124 $415, 
$968, respectively). cOnclusiOns: The economics of pediatric AD in AP has not 
been extensively studied. Based on available evidence, annual pediatric AD costs are 
generally high. Variations in cost estimates are due to between-study differences in 
country of analysis, types of costs included, severity of AD, and costing methodol-
ogy. Further evaluations of the AD costs and the cost-effectiveness of pediatric AD 
prevention strategies in AP countries are warranted.
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Objectives: Children with a family history of atopic disease receiving cow’s milk 
formula (CMF) are at high risk of atopic dermatitis (AD). Modeling techniques were 
used to estimate the economic impact of AD among urban high-risk children in 
Malaysia, Indonesia, and Singapore. MethOds: A cohort Markov model was devel-
oped to simulate the cumulative incidence and costs of AD in 3 cohorts (one per 
country) of urban, high-risk infants partially of completely fed with CMF in early 
infancy (months 0-4). AD incidence was from the GINI study, the largest/longest 
prospective experimental study of infant formula and AD in this population. AD 
treatment patterns and resource use assumptions were dervided from expert opin-
ion (n= 8). Costing of resource use was based on the respective countries’ prices. 
Key modeled outcomes included the overall and annual direct/indirect costs of 
AD (converted to 2013 US$) from diagnosis to age 6. Multivariate probabilistic sen-
sitivity analysis was uses to generate 95% confidence intervals (CI) around study 
outcomes. Results: The 6-year cumulative risk of AD was 38% (95% CI: 22%, 57%). 
The mean overall estimated AD costs/child developing AD was $2,492 (95% CI: $1,887, 
$3,509) in Malaysia, $3,217 (95% CI: $2,339, $4,717) in Indonesia, and $4,753 (95% CI: 
$3,438, $6,961) in Singapore. Expressed on an annual basis, the cost of AD per child 
developing AD was $576 (95% CI: $501, $650) in Malaysia, $743 (95% CI: $605, $876) in 
Indonesia, and $1,097 (95% CI: $900, $1,303) in Singapore. Most of these costs were 
direct costs for physician visits and pharmacologic treatments. cOnclusiOns: By 
age 6, the total cumulative AD-related costs among high-risk urban infants who are 
fed with CMF in early infancy are estimated to range from $2,492 to $4,473. Annual 
AD costs range from $576 to $1,097. Cost-effective AD prevention strategies should 
be considered to reduce this burden.
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Objectives: Asthma is a major health care problem. Understanding current pat-
terns of health care utilization is important. Several previous studies compared 
health care utilization and cost by severity and health insurance; however, they may 
not be applicable to Thailand. This study aimed to compare health care utilization 
and cost by asthma severity and type of health insurance in Thailand. MethOds: 
A retrospective study using an electronic database was conducted in patients with 
asthma who visited a University-affiliated hospital during 2009-2011. The outcomes 
were health care utilization and costs of in-patient and out-patient care. We com-
pared outcomes between groups based on a proxy of severity (high vs. non-high 
risk of emergency department visit) and type of health insurance. Multivariable 
generalized linear regression model with log link function was used to determine 
the difference of average health care cost, while multivariable negative binomial 
